论文部分内容阅读
目的:评价消炎利胆片与诺氟沙星联用治疗慢性胆囊炎患者的临床效果。方法:选取2014年9月—2015年10月间治疗的慢性胆囊炎患者86例,将其分为观察组和对照组,每组43例;对照组患者均给予消炎利胆片治疗,观察组患者在对照组的基础上加用诺氟沙星胶囊治疗,评价两组患乾治疗后的总有效率和不良反应发生率。结果:观察组患者治疗后的总有效率为97.7%高于对照组为81.39%(P<0.05),观察组不良反应总发生率与对照组比较其差异无统计学意义(P>0.05)。结论:采用消炎利胆片与诺氟沙星胶囊联用于治疗慢性胆囊炎患者,能够提升临床治疗效果,改善患者的临床症状。
Objective: To evaluate the clinical effect of Xiaoyanlidan tablet combined with norfloxacin in patients with chronic cholecystitis. Methods: A total of 86 patients with chronic cholecystitis who were treated between September 2014 and October 2015 were selected and divided into observation group and control group, with 43 cases in each group. Patients in the control group were treated with Xiaoyanlidan tablet and observation group Patients in the control group plus norfloxacin capsules based on the evaluation of the two groups of patients after treatment of total effective rate and incidence of adverse reactions. Results: The total effective rate of observation group after treatment was 97.7% higher than that of control group (81.39%, P <0.05). The total incidence of adverse reactions in observation group was not significantly different from that in control group (P> 0.05). Conclusion: The combination of Xiaoyanlidan tablet and norfloxacin capsules for the treatment of patients with chronic cholecystitis can improve the clinical curative effect and improve the clinical symptoms of patients.